PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
BLIN vs. BLUE
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between BLIN and BLUE is 0.09, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.1

Performance

BLIN vs. BLUE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Bridgeline Digital, Inc. (BLIN) and bluebird bio, Inc. (BLUE). The values are adjusted to include any dividend payments, if applicable.

-100.00%-98.00%-96.00%-94.00%-92.00%AugustSeptemberOctoberNovemberDecember2025
-99.87%
-97.60%
BLIN
BLUE

Key characteristics

Sharpe Ratio

BLIN:

1.60

BLUE:

-0.46

Sortino Ratio

BLIN:

2.50

BLUE:

-0.31

Omega Ratio

BLIN:

1.32

BLUE:

0.96

Calmar Ratio

BLIN:

1.24

BLUE:

-0.71

Martin Ratio

BLIN:

6.25

BLUE:

-1.29

Ulcer Index

BLIN:

19.78%

BLUE:

54.77%

Daily Std Dev

BLIN:

77.23%

BLUE:

151.89%

Max Drawdown

BLIN:

-99.99%

BLUE:

-99.80%

Current Drawdown

BLIN:

-99.97%

BLUE:

-99.72%

Fundamentals

Market Cap

BLIN:

$18.13M

BLUE:

$81.18M

EPS

BLIN:

-$0.20

BLUE:

-$36.39

PEG Ratio

BLIN:

0.00

BLUE:

0.32

Total Revenue (TTM)

BLIN:

$11.60M

BLUE:

$45.29M

Gross Profit (TTM)

BLIN:

$7.58M

BLUE:

-$21.31M

EBITDA (TTM)

BLIN:

-$661.00K

BLUE:

-$99.14M

Returns By Period

In the year-to-date period, BLIN achieves a 10.13% return, which is significantly higher than BLUE's 0.12% return. Over the past 10 years, BLIN has underperformed BLUE with an annualized return of -44.71%, while BLUE has yielded a comparatively higher -39.21% annualized return.


BLIN

YTD

10.13%

1M

29.85%

6M

77.55%

1Y

131.08%

5Y*

0.86%

10Y*

-44.71%

BLUE

YTD

0.12%

1M

-9.53%

6M

-60.24%

1Y

-67.00%

5Y*

-63.50%

10Y*

-39.21%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

BLIN vs. BLUE — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BLIN
The Risk-Adjusted Performance Rank of BLIN is 8686
Overall Rank
The Sharpe Ratio Rank of BLIN is 8888
Sharpe Ratio Rank
The Sortino Ratio Rank of BLIN is 8787
Sortino Ratio Rank
The Omega Ratio Rank of BLIN is 8585
Omega Ratio Rank
The Calmar Ratio Rank of BLIN is 8383
Calmar Ratio Rank
The Martin Ratio Rank of BLIN is 8585
Martin Ratio Rank

BLUE
The Risk-Adjusted Performance Rank of BLUE is 1818
Overall Rank
The Sharpe Ratio Rank of BLUE is 2222
Sharpe Ratio Rank
The Sortino Ratio Rank of BLUE is 2424
Sortino Ratio Rank
The Omega Ratio Rank of BLUE is 2424
Omega Ratio Rank
The Calmar Ratio Rank of BLUE is 88
Calmar Ratio Rank
The Martin Ratio Rank of BLUE is 1212
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

BLIN vs. BLUE - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Bridgeline Digital, Inc. (BLIN) and bluebird bio, Inc. (BLUE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for BLIN, currently valued at 1.60, compared to the broader market-2.000.002.004.001.60-0.46
The chart of Sortino ratio for BLIN, currently valued at 2.50, compared to the broader market-4.00-2.000.002.004.002.50-0.31
The chart of Omega ratio for BLIN, currently valued at 1.32, compared to the broader market0.501.001.502.001.320.96
The chart of Calmar ratio for BLIN, currently valued at 1.24, compared to the broader market0.002.004.006.001.24-0.71
The chart of Martin ratio for BLIN, currently valued at 6.25, compared to the broader market-10.000.0010.0020.0030.006.25-1.29
BLIN
BLUE

The current BLIN Sharpe Ratio is 1.60, which is higher than the BLUE Sharpe Ratio of -0.46. The chart below compares the historical Sharpe Ratios of BLIN and BLUE, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.00-0.500.000.501.001.502.002.50AugustSeptemberOctoberNovemberDecember2025
1.60
-0.46
BLIN
BLUE

Dividends

BLIN vs. BLUE - Dividend Comparison

Neither BLIN nor BLUE has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

BLIN vs. BLUE - Drawdown Comparison

The maximum BLIN drawdown since its inception was -99.99%, roughly equal to the maximum BLUE drawdown of -99.80%. Use the drawdown chart below to compare losses from any high point for BLIN and BLUE. For additional features, visit the drawdowns tool.


-100.00%-99.80%-99.60%-99.40%-99.20%AugustSeptemberOctoberNovemberDecember2025
-99.90%
-99.72%
BLIN
BLUE

Volatility

BLIN vs. BLUE - Volatility Comparison

Bridgeline Digital, Inc. (BLIN) has a higher volatility of 50.76% compared to bluebird bio, Inc. (BLUE) at 33.73%. This indicates that BLIN's price experiences larger fluctuations and is considered to be riskier than BLUE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%20.00%40.00%60.00%80.00%100.00%AugustSeptemberOctoberNovemberDecember2025
50.76%
33.73%
BLIN
BLUE

Financials

BLIN vs. BLUE - Financials Comparison

This section allows you to compare key financial metrics between Bridgeline Digital, Inc. and bluebird bio, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab